Tuesday, January 26, 2021
- Advertisement -

TAG

TXMD stock

TherapeuticsMD Inc. [TXMD] is 18.18% higher this YTD. Is it still time to buy?

TherapeuticsMD Inc. stock went on an upward path that rose over 0.70% on Wednesday, amounting to a one-week price increase of more than...

Wall Street Analyst Downgrade TherapeuticsMD Inc. [TXMD]. What else is Wall St. saying

TherapeuticsMD Inc. traded at a high on 01/11/21, posting a 6.77 gain after which it closed the day’ session at $1.42. The company...

Jefferies lifts TherapeuticsMD Inc. [TXMD] price estimate. Who else is bullish?

TherapeuticsMD Inc. stock went on a downward path that fall over -0.82% on Wednesday, amounting to a one-week price increase of more than...

Market cap of TherapeuticsMD Inc. [TXMD] reaches 389.70M – now what?

TherapeuticsMD Inc. closed the trading session at $1.32 on 12/04/20. The day’s price range saw the stock hit a low of $1.28, while...

TherapeuticsMD Inc. [TXMD] Stock trading around $1.35 per share: What’s Next?

TherapeuticsMD Inc. plunged by -$0.17 during the normal trading session on Tuesday and reaching a high of $1.48 during the day while it...

TherapeuticsMD Inc. [TXMD] Stock trading around $1.66 per share: What’s Next?

TherapeuticsMD Inc. jumped around 0.01 points on Monday, while shares priced at $1.66 at the close of the session, up 0.61%. The company...

Jefferies Downgrade TherapeuticsMD Inc. [TXMD]. What else is Wall St. saying?

TherapeuticsMD Inc. traded at a high on 09/17/20, posting a 3.70 gain after which it closed the day’ session at $1.40. The company...

Market cap of TherapeuticsMD Inc. [TXMD] reaches 394.81M – now what?

TherapeuticsMD Inc. gained 2.76% or 0.04 points to close at $1.49 with a heavy trading volume of 3212928 shares. The company report on...

JP Morgan Downgrade TherapeuticsMD Inc. [TXMD]. What else is Wall St. saying?

TherapeuticsMD Inc. closed the trading session at $1.96 on 07/29/20. The day’s price range saw the stock hit a low of $1.8299, while...

TherapeuticsMD Inc. [TXMD] is -46.07% lower this YTD. Is it still time to buy?

TherapeuticsMD Inc. plunged by -$0.01 during the normal trading session on Tuesday and reaching a high of $1.37 during the day while it...

Latest news

OncoCyte Corporation [OCX] is 144.77% higher this YTD. Is it still time to buy?

OncoCyte Corporation gained 22.90% or 1.09 points to close at $5.85 with a heavy trading volume of 4335606 shares. The company report on...

For InspireMD Inc. [NSPR], Analyst sees a rise to $4. What next?

InspireMD Inc. closed the trading session at $0.77 on 01/25/21. The day’s price range saw the stock hit a low of $0.66, while...

Market Analysts see Chico’s FAS Inc. [CHS] gaining to $1.50. Time to buy?

Chico's FAS Inc. jumped around 0.5 points on Monday, while shares priced at $2.68 at the close of the session, up 22.94%. The...

Molecular Data Inc. [MKD] Revenue clocked in at $2.04 billion, up 64.29% YTD: What’s Next?

Molecular Data Inc. stock went on a downward path that fall over -9.80% on Monday, amounting to a one-week price increase of more...

Lightbridge Corporation [LTBR] Is Currently 22.95 above its 200 Period Moving Avg: What Dose This Mean?

Lightbridge Corporation gained 22.95% on the last trading session, reaching $8.41 price per share at the time. The company report on January 13,...
- Advertisement -

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.